MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE TREATED WITH AN ANTI-TUMOR NECROSIS FACTOR AGENT

被引：0
|
作者：
Kim, Y. J. [1 ]
Koo, B. S. [1 ]
So, M. -W. [1 ]
Seo, W. J. [2 ]
Kim, Y-G. [1 ]
Lee, C-K. [1 ]
Yoo, B. [1 ]
机构：
[1] Univ Ulsan, Coll Med, Div Rheumatol, Dept Internal Med,Asan Med Ctr, Seoul, South Korea
[2] Seoul Vet Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [21] Assessment of income growth in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy
    Bergman, Martin
    De, Gourab
    Ganguli, Arijit
    Signorovitch, James
    Bao, Yanjun
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (01) : 37 - 44
  • [22] Related factors, increased mortality and causes of death in patients with rheumatoid arthritis-associated interstitial lung disease
    Kakutani, Takuya
    Hashimoto, Atsushi
    Tominaga, Akito
    Kodama, Kako
    Nogi, Shinichi
    Tsuno, Hirotaka
    Ogihara, Hideki
    Nunokawa, Takahiro
    Komiya, Akiko
    Furukawa, Hiroshi
    Tohma, Shigeto
    Matsui, Toshihiro
    MODERN RHEUMATOLOGY, 2020, 30 (03) : 458 - 464
  • [23] Quantitative chest imaging and prediction of mortality in rheumatoid arthritis-associated interstitial lung disease
    McDermott, Gregory
    Sparks, Jeffrey A.
    RHEUMATOLOGY, 2022, 61 (12) : 4583 - 4584
  • [24] Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease
    Zamora-Legoff, Jorge A.
    Krause, Megan L.
    Crowson, Cynthia S.
    Ryu, Jay H.
    Matteson, Eric L.
    CLINICAL RHEUMATOLOGY, 2016, 35 (10) : 2585 - 2589
  • [25] Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease
    Chang, Sung Hae
    Lee, Ji Sung
    Ha, You-Jung
    Kim, Min Uk
    Park, Chan Ho
    Lee, Jeong Seok
    Kim, Ji-Won
    Chung, Sang Wan
    Pyo, Jung Yoon
    Lee, Sung Won
    Kang, Eun Ha
    Lee, Yeon-Ah
    Park, Yong-Beom
    Choe, Jung-Yoon
    Lee, Eun Young
    RHEUMATOLOGY, 2023, 62 (09) : 3014 - 3024
  • [26] Clinical features of rheumatoid arthritis-associated interstitial lung disease
    Wang, Ting
    Zheng, Xing-Ju
    Liang, Bin-Miao
    Liang, Zong-An
    SCIENTIFIC REPORTS, 2015, 5
  • [27] Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease
    Jorge A. Zamora-Legoff
    Megan L. Krause
    Cynthia S. Crowson
    Jay H. Ryu
    Eric L. Matteson
    Clinical Rheumatology, 2016, 35 : 2585 - 2589
  • [28] Periostin Is a Biomarker of Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Matama, Goushi
    Okamoto, Masaki
    Fujimoto, Kiminori
    Johkoh, Takeshi
    Tominaga, Masaki
    Mukae, Hiroshi
    Sakamoto, Noriho
    Komiya, Kosaku
    Umeki, Kenji
    Komatsu, Masamichi
    Shimizu, Yasuo
    Takahashi, Koichiro
    Tokisawa, Saeko
    Zaizen, Yoshiaki
    Matsuo, Norikazu
    Nouno, Takashi
    Kaieda, Shinjiro
    Ida, Hiroaki
    Izuhara, Kenji
    Hoshino, Tomoaki
    Sebastiani, Marco
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)
  • [29] Pirfenidone in rheumatoid arthritis-associated interstitial lung disease Reply
    Hurwitz, Shelley
    Maurer, Rie
    Solomon, Joshua J.
    Rosas, Ivan
    LANCET RESPIRATORY MEDICINE, 2023, 11 (06): : E52 - E52
  • [30] Predictors Of Outcome In Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Solomon, J. J.
    Demoruelle, K.
    Mannina, A.
    Olson, A. L.
    Fischer, A.
    Perez, E. R. Fernandez
    Huie, T.
    Chung, J.
    Deane, K. D.
    Russell, G. M.
    Tsuchiya, Y.
    Brown, K. K.
    Swigris, J. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345